193 related articles for article (PubMed ID: 6403025)
21. Binding of human thrombin to human factor VIII:RAg.
Hau L; Firkin BG; Howard MA
Br J Haematol; 1986 Mar; 62(3):479-85. PubMed ID: 3082349
[TBL] [Abstract][Full Text] [Related]
22. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG
Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
[TBL] [Abstract][Full Text] [Related]
23. Electroblotting of factor VIII/von Willebrand factor multimers after electrophoresis in SDS-agarose gel, discontinuous buffer system.
Batlle J; López Fernández MF; López Berges C; López Borrasca A
Br J Haematol; 1983 Sep; 55(1):195-6. PubMed ID: 6411111
[No Abstract] [Full Text] [Related]
24. The complex multimeric composition of factor VIII/von Willebrand factor.
Ruggeri ZM; Zimmerman TS
Blood; 1981 Jun; 57(6):1140-3. PubMed ID: 6784794
[TBL] [Abstract][Full Text] [Related]
25. Profound alterations of the multimeric structure of von Willebrand factor in a patient with malignant lymphoma.
Tran-Thang C; Mannucci PM; Schneider P; Federici A; Bachmann F
Br J Haematol; 1985 Oct; 61(2):307-14. PubMed ID: 3929829
[TBL] [Abstract][Full Text] [Related]
26. Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imaging.
Pruthi RK; Daniels TM; Heit JA; Chen D; Owen WG; Nichols WL
Thromb Res; 2010 Dec; 126(6):543-9. PubMed ID: 20889192
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120).
Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H
Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753
[TBL] [Abstract][Full Text] [Related]
28. Type IB von Willebrand's disease and pregnancy: comparison of analytical methods of von Willebrand factor for classification of von Willebrand's disease subtypes.
Takahashi H; Hayashi N; Shibata A
Thromb Res; 1988 May; 50(3):409-18. PubMed ID: 3260697
[TBL] [Abstract][Full Text] [Related]
29. Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry.
Studt JD; Budde U; Schneppenheim R; Eisert R; von Depka Prondzinski M; Ganser A; Barthels M
Am J Clin Pathol; 2001 Oct; 116(4):567-74. PubMed ID: 11601142
[TBL] [Abstract][Full Text] [Related]
30. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
[TBL] [Abstract][Full Text] [Related]
31. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
Aihara M; Kimura A; Chiba Y; Yoshida Y
Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
[TBL] [Abstract][Full Text] [Related]
32. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
33. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
Yoshioka A
Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
[No Abstract] [Full Text] [Related]
34. Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment.
Goudemand J; Samor B; Caron C; Jude B; Gosset D; Mazurier C
Br J Haematol; 1988 Feb; 68(2):227-33. PubMed ID: 3126793
[TBL] [Abstract][Full Text] [Related]
35. Clinical and laboratory evaluation of National Health Service factor VIII concentrate (8Y) for the treatment of von Willebrand's disease.
Cumming AM; Fildes S; Cumming IR; Wensley RT; Redding OM; Burn AM
Br J Haematol; 1990 Jun; 75(2):234-9. PubMed ID: 2115374
[TBL] [Abstract][Full Text] [Related]
36. Isoelectric focusing of human von Willebrand factor in urea-agarose gels.
Fulcher CA; Ruggeri ZM; Zimmerman TS
Blood; 1983 Feb; 61(2):304-10. PubMed ID: 6600402
[TBL] [Abstract][Full Text] [Related]
37. Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis.
Metzner HJ; Hermentin P; Cuesta-Linker T; Langner S; Müller HG; Friedebold J
Haemophilia; 1998; 4 Suppl 3():25-32. PubMed ID: 10028315
[TBL] [Abstract][Full Text] [Related]
38. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease.
McCarroll DR; Ruggeri ZM; Montgomery RR
J Lab Clin Med; 1984 May; 103(5):704-11. PubMed ID: 6609219
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
Budde U; Metzner HJ; Müller HG
Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique.
Enayat MS; Hill FG
J Clin Pathol; 1983 Aug; 36(8):915-9. PubMed ID: 6409946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
